Albert Bourla, Pfizer CEO (Evan Vucci/AP Images)
July 23, 2021 07:22 AM EDTUpdated July 26, 07:08 AM
Coronavirus

Covid-19 roundup: Pfiz­er to sup­ply US with 200M more vac­cines as UK study finds high­er an­ti­bod­ies in 8-10 week in­ter­vals

Max Gelman

Senior Editor

Zachary Brennan

Senior Editor

The US gov­ern­ment has pur­chased 200 mil­lion more dos­es of the Pfiz­er/BioN­Tech vac­cine, the com­pa­nies an­nounced Fri­day morn­ing.

Pfiz­er and BioN­Tech ex­pect to de­liv­er 110 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Viking CEO on ‘shock­ing’ mar­ket re­ac­tion to oral obe­si­ty da­ta, prepar­ing for Phase 3

Sana nar­rows fo­cus again to ze­ro in on di­a­betes and au­toim­mune dis­ease

Ver­tex makes mon­ey from sick­le cell ther­a­py Cas­gevy

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

Is there room for MASH drugs in a GLP-1 world?

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times